Beverly M.K. Biller, M.D.
Co-Author
This page shows the publications co-authored by Beverly Biller and Anne Klibanski.
Connection Strength
4.262
-
Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency. J Clin Endocrinol Metab. 2000 Mar; 85(3):970-6.
Score: 0.215
-
A decade of the Massachusetts General Hospital Neuroendocrine Clinical Center. J Clin Endocrinol Metab. 1997 Jun; 82(6):1668-74.
Score: 0.178
-
Effectiveness of first-line pegvisomant monotherapy in acromegaly: an ACROSTUDY analysis. Eur J Endocrinol. 2017 Feb; 176(2):213-220.
Score: 0.171
-
Dopamine Agonists Can Reduce Cystic Prolactinomas. J Clin Endocrinol Metab. 2016 10; 101(10):3709-3715.
Score: 0.168
-
Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline. J Clin Endocrinol Metab. 1996 Jun; 81(6):2338-43.
Score: 0.166
-
Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis. J Clin Endocrinol Metab. 2014 Jun; 99(6):2018-29.
Score: 0.143
-
Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study. Pituitary. 2014 Apr; 17(2):150-6.
Score: 0.143
-
Pathologic and clinical features of pituitary adenomas showing TSH immunoreactivity. Pituitary. 2013 Sep; 16(3):287-93.
Score: 0.137
-
Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease. J Clin Endocrinol Metab. 1992 Nov; 75(5):1303-9.
Score: 0.130
-
Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. J Clin Endocrinol Metab. 1992 Sep; 75(3):692-7.
Score: 0.128
-
Osteopenia in women with hypothalamic amenorrhea: a prospective study. Obstet Gynecol. 1991 Dec; 78(6):996-1001.
Score: 0.122
-
Clinical Review#: Potential cardiac valve effects of dopamine agonists in hyperprolactinemia. J Clin Endocrinol Metab. 2010 Mar; 95(3):1025-33.
Score: 0.107
-
Abnormal cortisol secretion and responses to corticotropin-releasing hormone in women with hypothalamic amenorrhea. J Clin Endocrinol Metab. 1990 Feb; 70(2):311-7.
Score: 0.107
-
Delayed remission after transsphenoidal surgery in patients with Cushing's disease. J Clin Endocrinol Metab. 2010 Feb; 95(2):601-10.
Score: 0.107
-
Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement. J Clin Endocrinol Metab. 2010 Feb; 95(2):567-77.
Score: 0.107
-
Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy. J Endocrinol Invest. 2009 Dec; 32(11):924-33.
Score: 0.106
-
Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome. J Clin Endocrinol Metab. 2009 Dec; 94(12):4851-9.
Score: 0.105
-
Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study. Clin Endocrinol (Oxf). 2010 Jan; 72(1):53-8.
Score: 0.101
-
Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab. 1989 Mar; 68(3):548-54.
Score: 0.100
-
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2008 Jul; 93(7):2454-62.
Score: 0.095
-
Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2008 Jun; 93(6):2063-71.
Score: 0.094
-
Effects of testosterone therapy on cardiovascular risk markers in androgen-deficient women with hypopituitarism. J Clin Endocrinol Metab. 2007 Jul; 92(7):2474-9.
Score: 0.088
-
Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2006 May; 91(5):1683-90.
Score: 0.081
-
Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. J Clin Endocrinol Metab. 2005 Feb; 90(2):768-74.
Score: 0.075
-
Diagnostic errors after inferior petrosal sinus sampling. J Clin Endocrinol Metab. 2004 Aug; 89(8):3752-63.
Score: 0.073
-
The role of the clinical laboratory in the diagnosis of Cushing syndrome. Am J Clin Pathol. 2003 Dec; 120 Suppl:S38-45.
Score: 0.070
-
Androgens and bone density in women with hypopituitarism. J Clin Endocrinol Metab. 2002 Jun; 87(6):2770-6.
Score: 0.063
-
Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial. J Clin Endocrinol Metab. 2001 Apr; 86(4):1518-24.
Score: 0.058
-
Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med. 2000 Jul 18; 133(2):111-22.
Score: 0.055
-
Accuracy of Laboratory Tests for the Diagnosis of Cushing Syndrome. J Clin Endocrinol Metab. 2020 06 01; 105(6).
Score: 0.055
-
All-cause mortality in patients with acromegaly treated with pegvisomant: an ACROSTUDY analysis. Eur J Endocrinol. 2020 Mar; 182(3):285-292.
Score: 0.054
-
Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. J Clin Endocrinol Metab. 1998 Sep; 83(9):3184-9.
Score: 0.049
-
Characterization of cyclic Cushing's disease using late night salivary cortisol testing. Clin Endocrinol (Oxf). 2018 09; 89(3):336-345.
Score: 0.048
-
Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly. Pituitary. 2017 Dec; 20(6):668-675.
Score: 0.046
-
Bone microarchitecture and estimated bone strength in men with active acromegaly. Eur J Endocrinol. 2017 Nov; 177(5):409-420.
Score: 0.045
-
Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab. 1997 May; 82(5):1332-7.
Score: 0.044
-
Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med. 1996 Dec 01; 125(11):883-90.
Score: 0.043
-
Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men--a clinical research center study. J Clin Endocrinol Metab. 1996 Jan; 81(1):84-92.
Score: 0.040
-
Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease. J Clin Endocrinol Metab. 2015 Oct; 100(10):3770-7.
Score: 0.039
-
The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab. 1995 Mar; 80(3):898-904.
Score: 0.038
-
Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly. Clin Endocrinol (Oxf). 2012 Sep; 77(3):430-8.
Score: 0.032
-
Transsphenoidal surgery for cushing disease after nondiagnostic inferior petrosal sinus sampling. Neurosurgery. 2012 Jul; 71(1):14-22.
Score: 0.032
-
Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders. Endocr Pract. 2012 Mar-Apr; 18(2):209-18.
Score: 0.031
-
Osteopenia in men with a history of delayed puberty. N Engl J Med. 1992 Feb 27; 326(9):600-4.
Score: 0.031
-
Adipokines and cardiovascular risk in Cushing's syndrome. Neuroendocrinology. 2012; 95(3):187-206.
Score: 0.030
-
Clinical features of nonpituitary sellar lesions in a large surgical series. Clin Endocrinol (Oxf). 2010 Dec; 73(6):798-807.
Score: 0.028
-
Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest. 1990 Jul; 86(1):336-40.
Score: 0.028
-
Age and bone mass in premenopausal women. J Bone Miner Res. 1989 Aug; 4(4):533-8.
Score: 0.026
-
Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly. J Clin Endocrinol Metab. 2009 Jul; 94(7):2471-7.
Score: 0.025
-
Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors. J Clin Endocrinol Metab. 1989 Jan; 68(1):81-6.
Score: 0.025
-
Effects of prolactin and estrogen deficiency in amenorrheic bone loss. J Clin Endocrinol Metab. 1988 Jul; 67(1):124-30.
Score: 0.024
-
Management of recurrent and refractory Cushing's disease with reoperation and/or proton beam radiosurgery. Clin Neurosurg. 2008; 55:141-4.
Score: 0.023
-
Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas. J Clin Endocrinol Metab. 2008 Feb; 93(2):393-9.
Score: 0.023
-
Proton stereotactic radiosurgery in management of persistent acromegaly. Endocr Pract. 2007 Nov-Dec; 13(7):726-34.
Score: 0.023
-
Diagnostic dilemmas in the management of hypothalamic-pituitary-adrenal disorders. Ann N Y Acad Sci. 1987; 512:338-50.
Score: 0.022
-
Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2004 May; 89(5):2048-56.
Score: 0.018
-
Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med. 1999 May 18; 130(10):821-4.
Score: 0.013
-
Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab. 1998 Oct; 83(10):3419-26.
Score: 0.012
-
Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg. 1993 May; 78(5):753-61.
Score: 0.008
-
Treatment of prolactin-secreting pituitary macroadenomas with the long-acting non-ergot dopamine agonist CV 205-502. Ann Intern Med. 1990 May 01; 112(9):668-73.
Score: 0.007
-
Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome. Radiology. 1989 Feb; 170(2):515-8.
Score: 0.006
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.